Novartis team
Easy Reads

Group dynamic

Collaboration is the key to scientific success. Without a sound group setup, most research, production and distribution projects would be impossible to lift. The complexity of today’s pharmaceutical industry requires teams not only to perform at their very best, but to remain open to change so that they can adapt quickly when necessary. Agility is the name of the game.

Published on 09/05/2023

Photos by Laurids Jensen and Andy Kwok
The Lab2Lab team: Ingo Muckenschnabel, Daniel Schmid, Jorge Clerigues Blasco and Franziska Schneider.

The Lab2Lab team: Ingo Muckenschnabel, Daniel Schmid, Jorge Clerigues Blasco and Franziska Schneider.

FMI Luethi team (from left to right): Mathias Mahn, Andreas Luethi, Kitti Rusznak, Nigel Whittle, David Ruel, Julian Hinz, Sigrid Mueller, Martin Zeller, Iris Odstrcil, Nikolas Karalis, Tobias Eichlisberger, Nikos Armeniakos. Seated: Sivan Kanner, Maria Sol Fustiñana, Andras Szoenyi.

FMI Luethi team (from left to right): Mathias Mahn, Andreas Luethi, Kitti Rusznak, Nigel Whittle, David Ruel, Julian Hinz, Sigrid Mueller, Martin Zeller, Iris Odstrcil, Nikolas Karalis, Tobias Eichlisberger, Nikos Armeniakos. Seated: Sivan Kanner, Maria Sol Fustiñana, Andras Szoenyi.

The Fermentation team (from left to right): Eric Weber, Pierre Pannini, Regis Kessler, Mathieu Vonach, Hugo Regenass, Guillaume Vetter, Lionel Brogly.

The Fermentation team (from left to right): Eric Weber, Pierre Pannini, Regis Kessler, Mathieu Vonach, Hugo Regenass, Guillaume Vetter, Lionel Brogly.

The T-Charge team (from left to right): Jens Zeller, Annkatrin Pansa, Bjoern Giner, Alessandro Linciano, Sina Berndl, Markus Ebner, Imke Dreesen, Yasemin Kaynar, Lukas Stark, Nicolas Frisch.

The T-Charge team (from left to right): Jens Zeller, Annkatrin Pansa, Bjoern Giner, Alessandro Linciano, Sina Berndl, Markus Ebner, Imke Dreesen, Yasemin Kaynar, Lukas Stark, Nicolas Frisch.

Thanks for reading Live.Magazine

Stay connected by subscribing to our newsletter

Subscribe

By submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.